The Longevity Science Foundation releases an NFT collection to fund researches
To improve your local-language experience, sometimes we employ an auto-translation plugin. Please note auto-translation may not be accurate, so read original article for precise information.
Zurich-based Longevity Science Foundation partners with artist Nikita Replyanski to develop a science-themed “Longevity Volumes” NFT collection.
Nikita Replyanski is a phygital artist who has previously worked with Adidas, ASICS, Adobe, and other major companies. The artworks from his new collection depict the intersection of nature and technology, focusing viewers’ attention on the importance of both.
Seventy percent of income from primary sales will be donated to the Longevity Science Foundation’s treasury. Further, the Foundation will provide grants to longevity-focused research and projects that have successfully undergone due diligence. The Foundation will focus on the following areas: therapeutics, personalized medicine, predictive diagnostics, and artificial intelligence.
Additionally, The Longevity Science Foundation will provide startups with support, Visionary Boards reviews, and member voting. The collection is due in autumn this year.
“We want to share our mission of extending the healthy human lifespan with the NFT audience and introduce them to the concept of longevity. Our field is abundant with possibilities, both scientific and investment ones. We strive toward democratising the longevity industry, and our NFT project will enable individuals interested in this field to support cutting-edge longevity research that would typically remain in a closed institutional environment. Aside from that, our NFTs will feature unique perks, allowing them to function as a transparent fundraising tool and simultaneously provide donors with unique perks.”says the Operational Lead at Longevity Science Foundation, Garri Zmudze.
About The Longevity Science Foundation
The Longevity Science Foundation is a non-profit organization that aims to provide every human access to longevity-focused care. The company plans to do so by bringing science on ageing from the laboratory to the mass, making it mainstream. As longevity-focused care is rare, frequently limited groups of people can access it. The Foundation identifies necessary scientific innovations and provides funding for them, accelerating the advancement of mainstream longevity care.
Read related posts:
In line with the Trust Project guidelines, please note that the information provided on this page is not intended to be and should not be interpreted as legal, tax, investment, financial, or any other form of advice. It is important to only invest what you can afford to lose and to seek independent financial advice if you have any doubts. For further information, we suggest referring to the terms and conditions as well as the help and support pages provided by the issuer or advertiser. MetaversePost is committed to accurate, unbiased reporting, but market conditions are subject to change without notice.